tiprankstipranks
Marvel Biosciences Corp (TSE:MRVL)
:MRVL
Canadian Market
Holding TSE:MRVL?
Track your performance easily

Marvel Biosciences Corp (MRVL) Financial Statements

19 Followers

Marvel Biosciences Corp Financial Overview

Marvel Biosciences Corp's market cap is currently ―. The company's EPS TTM is C$-0.063; its P/E ratio is ―; Marvel Biosciences Corp is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 24Jan 24Oct 23Jul 23Apr 23
Income Statement-
Total Revenue-----
Gross Profit--$ -211.66K$ -618.54K$ -254.36K
EBIT$ -307.31K$ -232.81K$ -497.59K$ -1.03M$ -714.22K
EBITDA$ -307.31K$ -232.81K$ -497.59K$ -1.03M$ -714.22K
Net Income Common Stockholders$ -307.31K$ -232.81K$ -518.30K$ -1.05M$ -714.22K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 217.69K$ 577.67K$ 316.98K$ 556.62K$ 1.00M
Total Assets$ 347.27K$ 711.16K$ 434.75K$ 672.39K$ 1.22M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 3.10M$ 3.17M$ 2.66M$ 2.39M$ 1.75M
Stockholders Equity$ -2.76M$ -2.45M$ -2.23M$ -1.72M$ -528.62K
Cash Flow-
Free Cash Flow$ -359.98K$ -239.31K$ -239.64K$ -445.56K$ -296.14K
Operating Cash Flow$ -359.98K$ -239.31K$ -239.64K$ -445.56K$ -296.14K
Investing Cash Flow-----
Financing Cash Flow-$ 500.00K--$ 1.00M
Currency in USD

Marvel Biosciences Corp Earnings and Revenue History

Marvel Biosciences Corp Debt to Assets

Marvel Biosciences Corp Cash Flow

Marvel Biosciences Corp Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis